Aspirin/meprobamate

Aspirin/meprobamate
Combination of
AspirinNSAID
MeprobamateAnxiolytic
Clinical data
Trade namesEquagesic
AHFS/Drugs.comMicromedex Detailed Consumer Information
Routes of
administration		Oral
ATC code
Legal status
Legal status
Identifiers
CAS Number

Aspirin/meprobamate, sold under the brand name Equagesic (/ˌɛkwəˈdʒiːzɪk/), is a combination drug of aspirin and meprobamate indicated for short-term pain treatment accompanied by tension or anxiety in patients with musculoskeletal disorders or tension headache. Some formulations also contain ethoheptazine, an opioid analgesic.

Adverse effects

Other combinations

There also appears to be a combination with ethoheptazine, an opioid analgesic.

Society and culture

Equagesic was discontinued in the United States, because of its possible toxic effects, specifically of meprobamate.[medical citation needed] It was credited with the sudden death of actor Bruce Lee in 1973. Lee suffered a fatal hypersensitive reaction to one of the prescription drug's ingredients while working in Hong Kong.

References

  1. ↑ "Equagesic". NetDoctor.co.uk. Archived from the original on 27 September 2007. Discontinued in the UK – March 2002
  2. ↑ "Meprobamate Tablets 400mg – Summary of Product Characteristics (SmPC) – (emc)". www.medicines.org.uk. Retrieved 2021-08-09.
  3. ↑ Chang R (7 June 2020). "Bruce Lee: The Mystery Surrounding the Martial Artist's Death". Biography. Retrieved 2021-08-09.
  4. ↑ "Bruce Lee". Bruce Lee. Retrieved 2021-08-09.